Cetrorelix

Category
peptide
Half-Life (t½)
SC: 63h
Formula
C70H92ClN17O14
Molecular Weight
1431 g/mol
PubChem CID
25074887
Aliases
Cetrotide, SB-75

Pharmacological Mechanism

Decapeptide GnRH antagonist (D-Nal⁶ substitution and acetylated N-terminus) developed from ovine GnRH-antagonist templates. In controlled ovarian stimulation, direct GnRH-R blockade prevents the premature LH surge without the 2-week agonist down-regulation protocol — enabling shorter IVF cycles. Single 3 mg dose covers ~4 days; multiple 0.25 mg daily doses dial the antagonism more precisely.

Half-Life & Elimination Curve (SC: 63h)

100%50%25%12.5%0%0h0×t½63h1×t½5.3d2×t½7.9d3×t½10.5d4×t½13.1d5×t½0×t½ (0h): 100% remaining (~34.1 µg/L)1×t½ (63h): 50% remaining (~17 µg/L)2×t½ (5.3d): 25% remaining (~8.52 µg/L)3×t½ (7.9d): 12.5% remaining (~4.26 µg/L)4×t½ (10.5d): 6.3% remaining (~2.13 µg/L)5×t½ (13.1d): 3.1% remaining (~1.07 µg/L)
Plasma (SC)t½ Decay (63h)
  • 0×t½0h100% (34.1 µg/L)
  • 1×t½63h50% (17 µg/L)
  • 2×t½5.3d25% (8.52 µg/L)
  • 3×t½7.9d12.5% (4.26 µg/L)
  • 4×t½10.5d6.3% (2.13 µg/L)
  • 5×t½13.1d3.1% (1.07 µg/L)
Elimination t½63h (SC)
Rate Constant (ke)0.011 h⁻¹
Time to Peak (Tmax)6.03h
Est. Peak (Cmax)34.1 µg/L
Clearance (CL)0.77 L/h
97% Washout (5×t½)13.1d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References